{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:12:49Z","timestamp":1789053169391,"version":"build-2803163510"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Since its discovery, most research on fibroblast growth factor 21 (FGF21) has focused on its antihyperglycemia properties. However, attention has recently shifted towards elucidating the ability of FGF21 to lower circulating lipid levels and ameliorate liver inflammation and steatosis. We here discuss the physiology of FGF21 and its role in lipid metabolism, with a focus on genetics, which has up until now not been fully appreciated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>\n                      New developments have uncovered associations of common small-effect variants of the\n                      <jats:italic toggle=\"yes\">FGF21<\/jats:italic>\n                      gene, such as the single nucleotide polymorphisms rs2548957 and rs838133, with numerous physiological, biochemical and behavioural phenotypes linked to energy metabolism and liver function. In addition, rare loss-of-function variants of the cellular receptors for FGF21 have been recently associated with severe endocrine and metabolic phenotypes. These associations corroborate the findings from basic studies and preliminary clinical investigations into the therapeutic potential of FGF21 for the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridemia. Furthermore, recent breakthrough research has begun to dissect mechanisms of a potential FGF21 brain-adipose axis. Such inter-organ communication would be comparable to that seen with other potent metabolic hormones. A deeper understanding of FGF21 could prove to be further beneficial for drug development.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>FGF21 is a potent regulator of lipid and energy homeostasis and its physiology is currently at the centre of investigative efforts to develop agents targeting hypertriglyceridemia and MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mol.0000000000000960","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T09:03:40Z","timestamp":1729847020000},"page":"88-95","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Fibroblast growth factor 21: update on genetics and molecular biology"],"prefix":"10.1097","volume":"36","author":[{"given":"Daniel R.","family":"Barros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"R1-20250414","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/s41591-023-02427-z","article-title":"The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial","volume":"29","author":"Bhatt","year":"2023","journal-title":"Nat Med"},{"key":"R2-20250414","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N Engl J Med"},{"key":"R3-20250414","doi-asserted-by":"crossref","first-page":"20160016","DOI":"10.1515\/hmbci-2016-0016","article-title":"The regulation of FGF21 gene expression by metabolic factors and nutrients","volume":"30","author":"Erickson","year":"2017","journal-title":"Horm Mol Biol Clin Investig"},{"key":"R4-20250414","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/a-0879-2968","article-title":"Circulating FGF21 levels in human health and metabolic disease","volume":"128","author":"Keuper","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R5-20250414","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"R6-20250414","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"R7-20250414","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/a-1778-4159","article-title":"FGF21: a novel regulator of glucose and lipid metabolism and whole-body energy balance","volume":"54","author":"Szczepa\u0144ska","year":"2022","journal-title":"Horm Metab Res"},{"key":"R8-20250414","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"R9-20250414","article-title":"FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases","volume":"30","author":"Sonoda","year":"2017","journal-title":"Horm Mol Biol Clin Investig"},{"key":"R10-20250414","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2016.01.006","article-title":"FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues","volume":"23","author":"Schlein","year":"2016","journal-title":"Cell Metab"},{"key":"R11-20250414","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"R12-20250414","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","article-title":"FGF21 attenuates lipolysis in human adipocytes \u2013 a possible link to improved insulin sensitivity","volume":"582","author":"Arner","year":"2008","journal-title":"FEBS Lett"},{"key":"R13-20250414","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/j.febslet.2009.09.012","article-title":"Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob\/ob mice","volume":"583","author":"Li","year":"2009","journal-title":"FEBS Lett"},{"key":"R14-20250414","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1210\/en.2009-0119","article-title":"Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver","volume":"150","author":"Hotta","year":"2009","journal-title":"Endocrinology"},{"key":"R15-20250414","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.1210\/jc.2012-3107","article-title":"Mild cold exposure modulates fibroblast growth factor 21 (FGF21) diurnal rhythm in humans: relationship between FGF21 levels, lipolysis, and cold-induced thermogenesis","volume":"98","author":"Lee","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-20250414","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cmet.2014.07.012","article-title":"FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss","volume":"20","author":"Owen","year":"2014","journal-title":"Cell Metab"},{"key":"R17-20250414","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.3249","article-title":"FGF21 regulates metabolism and circadian behavior by acting on the nervous system","volume":"19","author":"Bookout","year":"2013","journal-title":"Nat Med"},{"key":"R18-20250414","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.2337\/db14-0541","article-title":"FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting","volume":"63","author":"Liang","year":"2014","journal-title":"Diabetes"},{"key":"R19-20250414","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-20250414","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molmet.2017.12.008","article-title":"Hepatic regulation of VLDL receptor by PPAR\u03b2\/\u03b4 and FGF21 modulates nonalcoholic fatty liver disease","volume":"8","author":"Zarei","year":"2018","journal-title":"Mol Metab"},{"key":"R21-20250414","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/mc.20494","article-title":"Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis","volume":"48","author":"Huang","year":"2009","journal-title":"Mol Carcinog"},{"key":"R22-20250414","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.510240132","article-title":"Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines","volume":"24","author":"Ogasawara","year":"1996","journal-title":"Hepatology"},{"key":"R23-20250414","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0168-8278(97)80085-2","article-title":"Basic fibroblast growth factor regulates proliferation and motility of human hepatoma cells by an autocrine mechanism","volume":"27","author":"Kin","year":"1997","journal-title":"J Hepatol"},{"key":"R24-20250414","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes"},{"key":"R25-20250414","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/TCRM.S352008","article-title":"Fibroblast growth factor-21 as a potential therapeutic target of nonalcoholic fatty liver disease","volume":"19","author":"Raptis","year":"2023","journal-title":"Ther Clin Risk Manag"},{"key":"R26-20250414","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.celrep.2019.02.014","article-title":"Exercise alleviates obesity-induced metabolic dysfunction via enhancing FGF21 sensitivity in adipose tissues","volume":"26","author":"Geng","year":"2019","journal-title":"Cell Rep"},{"key":"R27-20250414","doi-asserted-by":"crossref","first-page":"1150222","DOI":"10.3389\/fendo.2023.1150222","article-title":"Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho","volume":"14","author":"Aaldijk","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R28-20250414","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1210\/en.2015-1722","article-title":"Overexpression of \u03b2-klotho in adipose tissue sensitizes male mice to endogenous FGF21 and provides protection from diet-induced obesity","volume":"157","author":"Samms","year":"2016","journal-title":"Endocrinology"},{"key":"R29-20250414","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2017-00016","article-title":"Fibroblast growth factor 21-metabolic role in mice and men","volume":"38","author":"Staiger","year":"2017","journal-title":"Endocr Rev"},{"key":"R30-20250414","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"R31-20250414","doi-asserted-by":"crossref","first-page":"eaay5186","DOI":"10.1126\/scitranslmed.aay5186","article-title":"Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy","volume":"12","author":"Hernandez","year":"2020","journal-title":"Sci Transl Med"},{"key":"R32-20250414","first-page":"19","article-title":"Hepatic hormone FGF21 and its analogues in clinical trials","volume":"8","author":"Shao","year":"2022","journal-title":"Chron Dis Transl Med"},{"key":"R33-20250414","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7150\/ijbs.73936","article-title":"Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine","volume":"19","author":"Tan","year":"2023","journal-title":"Int J Biol Sci"},{"key":"R34-20250414","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol Endocrinol"},{"key":"R35-20250414","doi-asserted-by":"crossref","first-page":"155329","DOI":"10.1016\/j.metabol.2022.155329","article-title":"Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH","volume":"137","author":"Larsson","year":"2022","journal-title":"Metab Clin Exp"},{"key":"R36-20250414","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/nu13051504","article-title":"Genetic evidence supporting fibroblast growth factor 21 signalling as a pharmacological target for cardiometabolic outcomes and Alzheimer's disease","volume":"13","author":"Larsson","year":"2021","journal-title":"Nutrients"},{"key":"R37-20250414","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.celrep.2018.03.070","article-title":"A common allele in FGF21 associated with sugar intake Is associated with body shape, lower total body-fat percentage, and higher blood pressure","volume":"23","author":"Frayling","year":"2018","journal-title":"Cell Rep"},{"key":"R38-20250414","doi-asserted-by":"crossref","DOI":"10.1002\/ueg2.12534","article-title":"Fibroblast growth factor 21 is a hepatokine involved in MASLD progression","author":"Gallego-Dur\u00e1n","year":"2024","journal-title":"Unit Eur Gastroenterol J"},{"key":"R39-20250414","doi-asserted-by":"crossref","first-page":"2004168","DOI":"10.1002\/advs.202004168","article-title":"Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the fibroblast growth factor 21 locus","volume":"8","author":"Bayoumi","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"R40-20250414","doi-asserted-by":"crossref","first-page":"668901","DOI":"10.3389\/fnut.2021.668901","article-title":"Dietary patterns and their associations with the FTO and FGF21 gene variants among emirati adults","volume":"8","author":"Naja","year":"2021","journal-title":"Front Nutr"},{"key":"R41-20250414","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.3390\/nu13113954","article-title":"Single nucleotide polymorphisms in close proximity to the fibroblast growth factor 21 (FGF21) gene found to be associated with sugar intake in a Swedish oopulation","volume":"13","author":"Janzi","year":"2021","journal-title":"Nutrients"},{"key":"R42-20250414","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/ajcn\/nqz043","article-title":"New insight into human sweet taste: a genome-wide association study of the perception and intake of sweet substances","volume":"109","author":"Hwang","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"R43-20250414","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jare.2020.05.020","article-title":"The FGF-21 genetic variants rs838133 and rs838145 are associated with high salt intake in the Emirati population","volume":"24","author":"Saber-Ayad","year":"2020","journal-title":"J Advanc Res"},{"key":"R44-20250414","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41380-018-0079-4","article-title":"Genome-wide meta-analysis of macronutrient intake of 91,114 European ancestry participants from the cohorts for heart and aging research in genomic epidemiology consortium","volume":"24","author":"Merino","year":"2019","journal-title":"Mol Psychiatry"},{"key":"R45-20250414","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cmet.2017.04.009","article-title":"FGF21 is a sugar-induced hormone associated with sweet intake and preference in humans","volume":"25","author":"S\u00f8berg","year":"2017","journal-title":"Cell Metab"},{"key":"R46-20250414","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/hmg\/ddt032","article-title":"Novel locus including FGF21 is associated with dietary macronutrient intake","volume":"22","author":"Chu","year":"2013","journal-title":"Hum Mol Genet"},{"key":"R47-20250414","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3945\/ajcn.112.052183","article-title":"Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake","volume":"97","author":"Tanaka","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"R48-20250414","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1515\/jpem-2018-0546","article-title":"Association of the 3\u2019UTR polymorphism (rs11665896) in the FGF21 gene with metabolic status and nutrient intake in children with obesity","volume":"32","author":"Ruiz-Padilla","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"R49-20250414","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2337\/dc16-1111","article-title":"Macronutrient intake-associated FGF21 genotype modifies effects of weight-loss diets on 2-year changes of central adiposity and body composition: the POUNDS Lost trial","volume":"39","author":"Heianza","year":"2016","journal-title":"Diabetes Care"},{"key":"R50-20250414","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1073\/pnas.1611243113","article-title":"KLB is associated with alcohol drinking, and its gene product \u03b2-Klotho is necessary for FGF21 regulation of alcohol preference","volume":"113","author":"Schumann","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R51-20250414","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of nonalcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J Hepatol"},{"key":"R52-20250414","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-022-00868-3","article-title":"Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study","volume":"37","author":"Yuan","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"R53-20250414","doi-asserted-by":"crossref","first-page":"e0195147","DOI":"10.1371\/journal.pone.0195147","article-title":"Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: a longitudinal cohort study","volume":"13","author":"Okamoto","year":"2018","journal-title":"PLoS One"},{"key":"R54-20250414","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-2-5","article-title":"Fructose, insulin resistance, and metabolic dyslipidemia","volume":"2","author":"Basciano","year":"2005","journal-title":"Nutr Metab (Lond)"},{"key":"R55-20250414","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cmet.2015.12.003","article-title":"FGF21 mediates endocrine control of simple sugar intake and sweet taste preference by the liver","volume":"23","author":"von Holstein-Rathlou","year":"2016","journal-title":"Cell Metab"},{"key":"R56-20250414","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2020.06.008","article-title":"FGF21 signals to glutamatergic neurons in the ventromedial hypothalamus to suppress carbohydrate intake","volume":"32","author":"Jensen-Cody","year":"2020","journal-title":"Cell Metab"},{"key":"R57-20250414","doi-asserted-by":"crossref","first-page":"bvaa138","DOI":"10.1210\/jendso\/bvaa138","article-title":"Digenic variants in the FGF21 signaling pathway associated with severe insulin resistance and pseudoacromegaly","volume":"4","author":"Stone","year":"2020","journal-title":"J Endocr Soc"},{"key":"R58-20250414","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.15252\/emmm.201607376","article-title":"KLB, encoding \u03b2-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism","volume":"9","author":"Xu","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"(Suppl)","key":"R59-20250414","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin Mol Hepato"},{"key":"R60-20250414","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s13105-023-00987-9","article-title":"Involvement of the vagus nerve and hepatic gene expression in serum adiponectin concentrations in mice","volume":"80","author":"Hashimoto","year":"2024","journal-title":"J Physiol Biochem"},{"key":"R61-20250414","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41575-018-0062-1","article-title":"The metabolic role of vagal afferent innervation","volume":"15","author":"Waise","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R62-20250414","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1210\/endrev\/bnab008","article-title":"Multiorgan coordination of lipoprotein secretion by hormones, nutrients and neural networks","volume":"42","author":"Stahel","year":"2021","journal-title":"Endocr Rev"},{"key":"R63-20250414","doi-asserted-by":"crossref","first-page":"101351","DOI":"10.1016\/j.molmet.2021.101351","article-title":"GLP-1 physiology informs the pharmacotherapy of obesity","volume":"57","author":"Drucker","year":"2022","journal-title":"Mol Metab"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T06:00:30Z","timestamp":1744610430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000960","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]}}}